Research on influence of ginseng and heptahydrate complex prescription on T2DM rat skeletal muscle insulin resistance
The invention discloses a research on the influence of a ginseng-heptahydrate collateral prescription on skeletal muscle insulin resistance of T2DM rats, which comprises the following steps: preparing 80 SPF-level male SD rats with the weight of (200 +/-20) g, feeding the SD rats with free ingestion...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a research on the influence of a ginseng-heptahydrate collateral prescription on skeletal muscle insulin resistance of T2DM rats, which comprises the following steps: preparing 80 SPF-level male SD rats with the weight of (200 +/-20) g, feeding the SD rats with free ingestion and drinking water for 1 week every day, selecting 12 rats as a blank group by adopting a random number table method, feeding the rats with common feed, and feeding the rest rats with high-glucose and high-fat feed. The ginseng heptasaccharide collateral prescription can effectively improve IR and relieve T2DM, it is speculated that the treatment effect of the ginseng heptasaccharide collateral prescription is a certain body weight adjusting effect on T2DM rats, remarkable blood sugar reducing, glycolipid metabolism improving, insulin secretion promoting and insulin sensitivity increasing effects, and the action mechanism of the ginseng heptasaccharide collateral prescription may be that IRS1 expression is activat |
---|